Catalyst Wire Dossier Catalyst Wire Dossier

Ruxolitinib phosphate

ruxolitinib phosphate
Drug timelines are a Plus or Pro feature.

10 regulatory and trial events tracked for Ruxolitinib phosphate, covering 2016-09-14 to 2026-04-16. Get the full timeline:

Most recent: Clinical Trial Update: Ruxolitinib Phosphate in Reducing Fatigue in Patients With Chronic Lymphocytic Leukemia [Phase 2]

See pricing